Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with BOK, BCL2 family apoptosis regulator (BOK) [47], BAX and BAK are the only BCL2 family members characterized so far in mammalian cells for their ability to form pores across the outer mitochondrial membrane (OMM) and possibly other intracellular membranes [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“which is controlled by pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family, a group of proteins sharing one to four BCL2 homology (BH) domains (i.e., BH1, BH2, BH3, and BH4) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Intrinsic apoptosis is a form of RCD initiated by a variety of microenvironmental perturbations including (but not limited to) growth factor withdrawal, DNA damage, endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) overload, replication stress, microtubular alterations or mitotic defects [29–34].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Thus, most pro-survival BCL2 family members inhibit BAX and BAK by preventing their oligomerization and pore-forming activity either directly, upon physical sequestration at the OMM, or indirectly, following the sequestration of BH3-only activators [29, 64, 79, 110].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Self-citationThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Self-citation
Cited by
Items 701–800 of 1,008
Cellular and Molecular Responses to Mechanical Expansion of Tissue
Razzak, M. A., Hossain, M. S., Radzi, Z., Yahya, N. A., Czernuszka, J. T., & Rahman, M. T. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00540 · Cited by 51
“Too little apoptosis can promote cancer and autoimmune diseases; whereas, too much apoptosis can augment ischaemic conditions and drive neurodegeneration (Czabotar et al., 2014).”
BackgroundWang, Y., Yan, J., Zou, X.-L., Guo, K.-J., Zhao, Y., Meng, C., Yin, F., & Guo, L. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.024 · Cited by 53
Wang, J., Li, M., Zhang, W., Gu, A., Dong, J., Li, J., & Shan, A. (2018) · Toxins · doi:10.3390/toxins10100407 · Cited by 49
“Bax is the representative of apoptosis-promoting proteins, and Bcl-2 is a gene that inhibits apoptosis [71].”
BackgroundA panel of noncoding RNAs in non–small‐cell lung cancer
Bagheri, A., Khorshid, H. R. K., Tavallaie, M., Mowla, S. J., Sherafatian, M., Rashidi, M., Zargari, M., Boroujeni, M. E., & Hosseini, S. M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28111 · Cited by 46
Ge, Q., Guo, Y., Zheng, W., Zhao, S., Cai, Y., & Qi, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-87420-7 · Cited by 55
Yu, M., Pan, Q., Li, W., Du, T., Huang, F., Wu, H., He, Y., Wu, X., & Shi, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155045 · Cited by 50
Regulated cell death pathways in the sodium iodate model: Insights and implications for AMD
Upadhyay, M., & Bonilha, V. L. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109728 · Cited by 57
Mukherjee, N., Schwan, J. V., Fujita, M., Norris, D. A., & Shellman, Y. G. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.145 · Cited by 52
YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network
Véquaud, É., Séveno, C., Loussouarn, D., Engelhart, L., Campone, M., Juin, P. P., & Barillé‐Nion, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3638 · Cited by 46
“It relies on a proteolytic caspase-dependent cascade, to demantle cells and endow them with specific morphological characteristics [11, 12].”
BackgroundWang, X., Li, J., Wu, D., Bu, X., & Qiao, Y. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370215600548 · Cited by 46
“BCL-2 is the major member of BCL-2 family and essentially studied for its role in apoptosis.(15) Anti-apoptotic (Bcl-2, Bcl-XL and Bcl-w) and proapoptotic (Bax, Bcl-Xs, Bak and Bad) proteins constitute the BCL-2 family.”
BackgroundBhola, P. D., Mar, B. G., Lindsley, R. C., Ryan, J. A., Hogdal, L. J., Vo, T. T., DeAngelo, D. J., Galinsky, I. A., Ebert, B. L., & Letai, A. G. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82908 · Cited by 51
“Using BH3 domains, proapoptotic proteins either directly activate effector proteins BAX and BAK or antagonize antiapoptotic members (BCL-XL, BCL-2, BCLW, MCL1) (14).”
BackgroundNatural polyphenolic inhibitors against the antiapoptotic BCL-2
Verma, S., Singh, A. P., Kumari, A., Tyagi, C., Goyal, S., Jamal, S., & Grover, A. (2017) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2017.1298129 · Cited by 47
Post-translational control of T cell development by the ESCRT protein CHMP5
Adoro, S., Park, K. H., Bettigole, S. E., Lis, R., Shin, H. R., Seo, H., Kim, J. H., Knobeloch, K., Shim, J., & Glimcher, L. H. (2017) · Nature Immunology · doi:10.1038/ni.3764 · Cited by 53
Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach
Pavlopoulou, A., Bagos, P. G., Koutsandrea, V., & Georgakilas, A. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.023 · Cited by 55
Liu, X., Fan, Z., Li, Z., Jin, Z., Yan, D., Zhang, Y., Li, X., Tu, L., Xue, B., Chang, Y., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.010 · Cited by 46
“Among many antiapoptotic proteins, Bcl-2 is the most typical one located mainly in the outer mitochondrial membrane [6].”
BackgroundTopology of active, membrane-embedded Bax in the context of a toroidal pore
Bleicken, S., Assafa, T. E., Stegmueller, C., Wittig, A., García‐Sáez, A. J., & Bordignon, E. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0184-6 · Cited by 65
Wattanathamsan, O., Hayakawa, Y., & Pongrakhananon, V. (2019) · Phytotherapy Research · doi:10.1002/ptr.6422 · Cited by 47
Ye, A., Li, W., Zhou, L., Ao, L., Fang, W., & Li, Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.10.009 · Cited by 50
Yang, W., Xia, Y., Zou, Y., Meng, F., Zhang, J., & Zhong, Z. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b02953 · Cited by 45
Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology
Kathiresan, D. S., Balasubramani, R., Marudhachalam, K., Jaiswal, P., Ramesh, N., Suruthi, G. S., Moorthi, P. V., & Vijayan, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04469-x · Cited by 51
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
Baranski, Z., de Jong, Y., Ilkova, T., Peterse, E. F. P., Cleton-Jansen, A., van de Water, B., Hogendoorn, P. C. W., Bovée, J. V. M. G., & Danen, E. H. J. (2015) · Oncotarget · doi:10.18632/oncotarget.5333 · Cited by 50
“It is essential for development and tissue homeostasis, and can mediate cell death upon exposure to pathogens, cytotoxic agents, or oncogenic stress [6].”
BackgroundHabata, S., Iwasaki, M., 杉尾, 明., Suzuki, M., Tamate, M., Satohisa, S., Tanaka, R., & Saito, T. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3494 · Cited by 45
Hu, J., Lei, H., Fei, X., Liang, S., Xu, H., Qin, D., Wang, Y., Wu, Y., & Li, B. (2015) · Scientific Reports · doi:10.1038/srep17426 · Cited by 47
Feng, J., Li, S., & Chen, H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.041 · Cited by 46
Wu, L., Guo, X., Hartson, S. D., Davis, M. A., He, H., Medeiros, D. M., Wang, W., Clarke, S. L., Lucas, E. A., Smith, B. J., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600576 · Cited by 48
PUM1 promotes ovarian cancer proliferation, migration and invasion
Guan, X., Chen, S., Liu, Y., Wang, L., Zhao, Y., & Zong, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.078 · Cited by 45
Agle, K. A., Vincent, B. G., Piper, C., Belle, L., Zhou, V., Shlomchik, W. D., Serody, J. S., & Drobyski, W. R. (2018) · Blood · doi:10.1182/blood-2017-09-807156 · Cited by 51
The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
Jenie, R. I., Handayani, S., Susidarti, R. A., Udin, L. Z., & Meiyanto, E. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.059 · Cited by 47
“Decreasing Bcl-2 expression is followed by activation of caspases, leading to apoptosis.(32) Brazilin induces apoptosis through a caspase-dependent pathway.”
BackgroundThe pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme
Kaya-Aksoy, E., Cingöz, A., Senbabaoglu, F., Seker-Polat, F., Sur‐Erdem, İ., Kayabölen, A., Lokumcu, T., Şahin, G. N., Karahüseyinoğlu, S., & Onder, T. B. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0144-z · Cited by 48
Bcl-2 and IP3 compete for the ligand-binding domain of IP3Rs modulating Ca2+ signaling output
Ivanova, H., Wagner, L. E., Tanimura, A., Vandermarliere, E., Luyten, T., Welkenhuyzen, K., Alzayady, K. J., Wang, L., Hamada, K., Mikoshiba, K., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03091-8 · Cited by 45
Zhao, F., Li, H., Cao, F., Chen, X., Liang, Y., & Qiu, L. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.124590 · Cited by 46
Low molecular weight silicones induce cell death in cultured cells
Onnekink, C., Kappel, R. M., Boelens, W. C., & Pruijn, G. J. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-66666-7 · Cited by 49
Design of Protein Segments and Peptides for Binding to Protein Targets
Gupta, S., Azadvari, N., & Hosseinzadeh, P. (2022) · BioDesign Research · doi:10.34133/2022/9783197 · Cited by 49
“The critical residues in NOXA-B that are involved for binding were first identified by computational alanine scanning, using Robetta [131], and classified into a short motif and an extended motif.”
Autophagy and Apoptosis in Acute Brain Injuries: From Mechanism to Treatment
He, C., Xu, Y., Sun, J., Li, L., Zhang, J. H., & Wang, Y. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0094 · Cited by 47
“If apoptosis is inhibited by knocking out caspase or Bax/ Bak, autophagy will be activated as a backup and result in cellular death by degrading organelles excessively.”
InfluentialWeir, A. L., & Vince, J. E. (2022) · Biochemical Journal · doi:10.1042/bcj20210711 · Cited by 45
Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing
Zu, M., Hao, X., Ning, J., Zhou, X., Gong, Y., Lang, Y., Xu, W., Zhang, J., & Ding, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114751 · Cited by 53
Cell death controlling complexes and their potential therapeutic role
Zamaraev, A. V., Kopeina, G. S., Zhivotovsky, B., & Lavrik, I. N. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1757-2 · Cited by 47
“Thus, the further development of BH3 mimetics, in particular, in combinatory therapy is undoubtedly a promising strategy [101].”
Grabow, S., Delbridge, A. R. D., Valente, L. J., & Strasser, A. (2014) · Blood · doi:10.1182/blood-2014-09-601567 · Cited by 44
“The proapoptotic BH3-only proteins (BIM, PUMA, NOXA, BID, BAD, BIK,BMF,HRK) are essential for initiation of apoptosiswithdifferent death stimuli activating distinct members.(10,11) The proapoptotic multi-BH (BCL-2 homology) domain proteins BAX and BAK are required for activation of the downstream phases of apoptosis:…”
InfluentialSelf-citationSmall‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
Beekman, A. M., & Howell, L. A. (2015) · ChemMedChem · doi:10.1002/cmdc.201500497 · Cited by 45
FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies
Weeden, C. E., Solomon, B., & Asselin-Labat, M.-L. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.49 · Cited by 46
SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
Wang, X., Feng, H., Zhao, S., Xu, J., Wu, X., Cui, J. R., Zhang, Y., Qin, Y., Liu, Z., Gao, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14730 · Cited by 45
“Therefore, current therapies of these diseases are also designed to prevent or induce cell apoptosis directly or indirectly [5, 6].”
BackgroundPrateep, A., Sumkhemthong, S., Suksomtip, M., Pithi Chanvorachote, B., & Chaotham, C. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1325913 · Cited by 46
“The shift in cellular Bcl-2 family proteins toward an increase of pro-apoptotic proteins and/or a decrease of anti-apoptotic proteins results in the instability of mitochondrial membrane causing the release of cytochrome c to cytoplasm (Portt et al. 2011; Czabotar et al. 2014).”
BackgroundEnssle, J. C., Boedicker, C., Wanior, M., Vogler, M., Knapp, S., & Fulda, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.032 · Cited by 44
Pearce, M. C., Gamble, J. T., Kopparapu, P., O’Donnell, E. F., Mueller, M., Jang, H. S., Greenwood, J. A., Satterthwait, A. C., Tanguay, R. L., Zhang, X.-K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25437 · Cited by 47
“On the other hand, the pro-apoptotic Bcl-2 family members are divided into two subclasses, comprising the BH3 only proteins such as Noxa and Puma and multi-domain proteins such as Bak and Bax which possess the BH1-3 domains [14].”
BackgroundInfluentialAdvances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery
Xi, J., Zhang, R., Chen, K., Yao, L., Li, M., Jiang, R., Li, X., & Fan, L. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105848 · Cited by 47
Breathing new insights into the role of mutant p53 in lung cancer
Chen, T., Ashwood, L. M., Kondrashova, O., Strasser, A., Kelly, G., & Sutherland, K. D. (2025) · Oncogene · doi:10.1038/s41388-024-03219-6 · Cited by 46
Self-citationFunctions of the C-terminal domains of apoptosis-related proteins of the Bcl-2 family
Gómez-Fernández, J. C. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.05.003 · Cited by 44
Role of microRNA-195 in cardiomyocyte apoptosis induced by myocardial ischaemia–reperfusion injury
Gao, C., Liu, H., Cui, C., Liang, Z., Yao, H., & Tian, Y. (2016) · Journal of Genetics · doi:10.1007/s12041-016-0616-3 · Cited by 44
Assembly of Bak homodimers into higher order homooligomers in the mitochondrial apoptotic pore
Mandal, T., Shin, S., Aluvila, S., Chen, H., Grieve, C., Choe, J., Cheng, E. H. Y., Hustedt, E. J., & Oh, K. J. (2016) · Scientific Reports · doi:10.1038/srep30763 · Cited by 60
Park, J. E., Sun, Y., Lim, S. K., Tam, J. P., Dekker, M., Chen, H., & Sze, S. K. (2017) · Scientific Reports · doi:10.1038/srep40569 · Cited by 43
Retracted: The antiproliferative and apoptotic effects of apigenin on glioblastoma cells
Stump, T. A., Santee, B., Williams, L. P., Kunze, R., Heinze, C. E., Huseman, E. D., Gryka, R. J., Simpson, D. S., & Amos, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12718 · Cited by 46
RetractedAn essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation
Pei, Y., Banerjee, S., Jha, H. C., Sun, Z., & Robertson, E. S. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006500 · Cited by 42
Bordignon, E., & Bleicken, S. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.12.009 · Cited by 44
Das, S., Joardar, S., Manna, P., Dua, T. K., Bhattacharjee, N., Khanra, R., Bhowmick, S., Kalita, J., Saha, A., Ray, S., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1421438 · Cited by 48
“In the extrinsic pathway of apoptosis, the activation of FAS resulted in the cleavage of procaspase 8 into its cleaved/active form followed by activation of Bid signaling [55].”
Řehořová, M., Vargová, I., Forostyak, S., Vacková, I., Turnovcová, K., Skalníková, H. K., Vodička, P., Kubinová, Š., Syková, E., & Jendelová, P. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0223 · Cited by 44
Mongre, R. K., Mishra, C. B., Prakash, A., Jung, S., Lee, B. S., Kumari, S., Hong, J. T., & Lee, M.-S. (2019) · Cancers · doi:10.3390/cancers11091245 · Cited by 44
“Even, BCL-2 participates in the apoptosis and programmed cell death via upregulation of pro-apoptotic member such as BAX, BAK and BID [14,15].”
BackgroundInfluentialPotential hepatic and renal toxicity induced by the biflavonoids from Ginkgo biloba
Yun-Ying, L. I., Lu, X., Sun, J.-L., Wang, Q., Zhang, Y.-D., ZHANG, J.-B., & Fan, X. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30081-0 · Cited by 43
Computational Modeling as a Tool to Investigate PPI: From Drug Design to Tissue Engineering
Pérez, J. J., Pérez, R. A., & Pérez, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.681617 · Cited by 48
“…exhibiting pro-apoptotic activity and others pro-survival pro fi les, the apoptotic process is initiated by the interaction of pro-apoptotic and pro-survival members regulating mitochondrial outer membrane permeability, a crucial step in apoptosis (Chipuk et al., 2010; Czabotar et al., 2014).”
BackgroundLitwak, S. A., Wali, J. A., Pappas, E. G., Saadi, H., Stanley, W. J., Varanasi, L. C., Kay, T. W. H., Thomas, H. E., & Gurzov, E. N. (2015) · Journal of Diabetes Research · doi:10.1155/2015/280615 · Cited by 51
“There are three types of Bcl-2 proteins: prosurvival, proapoptotic Bcl-2 homology 3- (BH3-) only proteins and downstream multidomain proapoptotic effectors [12, 14].”
BackgroundHomilius, M., Zhu, W., Eddy, S. S., Thompson, P. C., Zheng, H., Warren, C. N., Evans, C. G., Kim, D. D., Xuan, L. L., Nsubuga, C., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01600-x · Cited by 45
“Besides TLR1 and several genes previously reported to regulate cell death (for example, CASP3 and BCL2A1 ) 33,34 , we also identified three metabolic genes, HK1 , PFKP and ACSL1 , associated with NE2/NE4 ratio at genome-wide significance (Figs.”
Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers
Torne, A. S., & Robertson, E. S. (2024) · Cancers · doi:10.3390/cancers16050991 · Cited by 49
“BID, alternatively known as the BH3-interacting domain death agonist, is a pro-apoptotic protein known to amplify caspase activation by linking the mitochondrial and death receptor-mediated apoptotic pathways [115].”
BackgroundMomordica Charantia lectin exhibits antitumor activity towards hepatocellular carcinoma
Zhang, C. Z., Fang, E. F., Zhang, H.-T., Liu, L.-L., & Yun, J. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0156-8 · Cited by 43
Folding and function in α/β-peptides: targets and therapeutic applications
Werner, H. M., & Horne, W. S. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.06.013 · Cited by 43
“[11] Anti-apoptotic Bcl-2 proteins, commonly overexpressed in tumor cells, exert their biological effect by binding to an amphiphilic αhelical BH3 domain on pro-apoptotic effectors, and the inhibition of this interaction has been an active target for development of cancer therapies.[12] The BH3 domain is an important…”
BackgroundTimilsina, U., & Gaur, R. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000402 · Cited by 45
Mitochondrial apoptosis and BH3 mimetics
Dai, H., Meng, X. W., & Kaufmann, S. H. (2016) · F1000Research · doi:10.12688/f1000research.9629.1 · Cited by 48
“…contain four BH domains and oppose MOM permeabilization; and the BH3-only proteins BIM, BID, PUMA, NOXA, BAD, BIK, BMF, and HRK, which share homology with other BCL2 family members only in their 15-amino-acid α -helical BH3 domain and induce apoptosis by facilitating BAX and/or BAK activation 22 .”
BackgroundAlterations in Ca2+ Signalling via ER-Mitochondria Contact Site Remodelling in Cancer
Kerkhofs, M., Giorgi, C., Marchi, S., Seitaj, B., Parys, J. B., Pinton, P., Bultynck, G., & Bittremieux, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_17 · Cited by 50
Li, L., Li, K., Mao, Y., Qu, H., Yao, B., Zhong, W., Ma, B., & Wang, Z.-Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4095 · Cited by 44
“Accordingly, the anti-apoptotic signals, Bcl-2 and Bcl-xl, were reduced by chrysophanol nanoparticles in prostate cancer cells (63).”
BackgroundPicornaviruses and Apoptosis: Subversion of Cell Death
Croft, S., Walker, E. J., & Ghildyal, R. (2017) · mBio · doi:10.1128/mbio.01009-17 · Cited by 44
Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies
Yalniz, F., & Wierda, W. G. (2019) · Drugs · doi:10.1007/s40265-019-01163-4 · Cited by 43
Kabir, S., Cidado, J. R., Andersen, C. L., Dick, C., Lin, P., Mitros, T., Ma, H., Baik, R., Belmonte, M. A., Drew, L., et al. (2019) · eLife · doi:10.7554/elife.44288 · Cited by 45
Characterization of an alternative BAK-binding site for BH3 peptides
Ye, K., Meng, W. X., Sun, H., Wu, B., Chen, M., Pang, Y., Gao, J., Wang, H., Wang, J., Kaufmann, S. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17074-y · Cited by 45
Hisam, N. S. N., Ugusman, A., Rajab, N. F., Ahmad, M. F., Fenech, M. F., Liew, S. L., & Anuar, N. N. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091353 · Cited by 47
“The first group consists of multiBH domain pro-apoptotic proteins (BAX and BAK), which act as apoptosis effectors; the second group includes the anti-apoptotic proteins (BCL-2, BCL-XL, BCL-W, MCL-1 and BFL-1), which prevent cell apoptosis; and the third group, which is comprised of BH3-only pro-apoptotic proteins (Nox…”
BackgroundThe roles of GTPase-activating proteins in regulated cell death and tumor immunity
He, H., Huang, J., Wu, S., Jiang, S., Liang, L., Liu, Y., Liu, W., Xie, L., Tao, Y., Jiang, Y., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01184-1 · Cited by 50
“This process is regulated by the BCL-2 family of proteins, mainly proapoptotic proteins (BAX, BAK, BIM, PUMA and BID) and antiapoptotic proteins (BCL-2, BCL-XL and MCL1) [14].”
BackgroundWang, C., Wang, L., Huang, C., Liu, Y., Liu, J., Kuang, H., Pang, Q., Han, H., & Fan, R. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115042 · Cited by 44
miR‑155 modulates high glucose‑induced cardiac fibrosis via the Nrf2/HO‑1 signaling pathway
Li, Y., Duan, J., He, Q., & Wang, C. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11495 · Cited by 46
Setia, N., Almuqdadi, H. T. A., & Abid, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116041 · Cited by 45
Zhou, Z., Mai, Y., Zhang, G., Wang, Y., Sun, P., Jing, Z., Li, Z., Xu, Y., Han, B. R., & Liu, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217079 · Cited by 46
Abdullah, A.-S. H., Mohammed, A. S., Abdullah, R., & Mirghani, M. E. S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023528 · Cited by 44
“This is supported by the decreasing trend of GSH concentration as a result of treatment with the extract.”
BackgroundInfluentialValente, L. J., Aubrey, B. J., Herold, M. J., Kelly, G. L., Happo, L., Scott, C. L., Newbold, A., Johnstone, R. W., Huang, D. C. S., Vassilev, L. T., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.059 · Cited by 41
“…it may be possible to boost its therapeutic efficacy by the addition of BH3 mimetic drugs, such as ABT-263 (Navitoclax) or ABT-199, which inhibit BCL-2, BCL-XL plus BCL-W, or BCL-2 alone, respectively (Czabotar et al., 2014). ll Reports 14, 1858–1866, March 1, 2016 ª2016 The Authors 1863 Figure 4.”
BackgroundSelf-citationYang, M., Nelson, R. W., & Ros, A. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03419 · Cited by 42
Regulation of platelet membrane protein shedding in health and disease
Au, A. E., & Josefsson, E. C. (2016) · Platelets · doi:10.1080/09537104.2016.1203401 · Cited by 45
Survival control of malignant lymphocytes by anti-apoptotic MCL-1
Fernández‐Marrero, Y., Spinner, S., Kaufmann, T., & Jost, P. J. (2016) · Leukemia · doi:10.1038/leu.2016.213 · Cited by 46
Cai, J., Xia, X., Liao, Y., Liu, N., Guo, Z., Chen, J., Li, Y., Long, H., Yang, Q., Zhang, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18774 · Cited by 41
“com/oncotarget release of cytochrome C (Cyto C) and apoptosis-inducing factor (AIF) from the mitochondria to cytoplasm [39, 40], indicating that the activation of apoptosis via the intrinsic pathway is a critical responder of b-AP15 treatment.”
BackgroundNeuroEPO Preserves Neurons from Glutamate-Induced Excitotoxicity
Garzón, F. M., Coimbra, D., Parcerisas, A., Rodriguez, Y., García, J. C., Soriano, E., & Rama, R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180668 · Cited by 46
Overexpression of acid ceramidase (ASAH1) protects retinal cells (ARPE19) from oxidative stress
Sugano, E., Edwards, G., Saha, S., Wilmott, L. A., Grambergs, R. C., Mondal, K., Qi, H., Stiles, M. A., Tomita, H., & Mandal, N. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m082198 · Cited by 46
“with pro- and anti-apoptotic pathways (79) are also decreased”
BackgroundKump, K. J., Miao, L., Mady, A. S. A., Ansari, N. H., Shrestha, U. K., Yang, Y., Pal, M., Liao, C., Perdih, A., Abulwerdi, F. A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01442 · Cited by 43
Zhang, Y., Yang, J., Wen, Z., Chen, X., Yu, J. H., Yuan, D., Xu, B., Luo, H., & Zhu, J. (2020) · Aging · doi:10.18632/aging.103178 · Cited by 47
Nath, H., Dutta, D., Sharma, P., Frontera, A., Verma, A. K., Barceló‐Oliver, M., Devi, M., & Bhattacharyya, M. K. (2020) · Dalton Transactions · doi:10.1039/d0dt01007c · Cited by 41
Saleh, H. M., & El-Shorbagy, H. M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.212 · Cited by 48
Scherr, A., Möck, A., Gdynia, G., Schmitt, N., Heilig, C. E., Korell, F., Rhadakrishnan, P., Hoffmeister‐Wittmann, P., Metzeler, K. H., Schulze‐Osthoff, K., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03092-7 · Cited by 47
Upadhyay, N., Tilekar, K. N., Loiodice, F., Anisimova, N. Y., Spirina, T. S., Sokolova, D. V., Smirnova, G. B., Choe, J., Meyer‐Almes, F., Pokrovsky, V. S., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104527 · Cited by 42
Gao, P., Chang, X., Zhang, D., Cai, Y., Chen, G., Wang, H., & Wang, T. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.004 · Cited by 43
Suleiman, J. B., Bakar, A. B. A., & Mohamed, M. (2021) · Molecules · doi:10.3390/molecules26113421 · Cited by 51
Roles and Regulation of BCL-xL in Hematological Malignancies
Morales-Martínez, M., & Vega, M. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042193 · Cited by 39
“Due to its participation in the regulation of apoptosis, a process whose evasion is directly related to the generation of malignant processes [7], alteration in the expression of the members of the BCL-2 family has been reported as fundamental in the generation and promotion of cancer [8].”
BackgroundKe, F., Holloway, S., Uren, R. T., Wong, A. W., Little, M. H., Kluck, R. M., Voss, A. K., & Strasser, A. (2022) · The EMBO Journal · doi:10.15252/embj.2021110300 · Cited by 56
“The latter group can be further classified into the multi-BH domain effectors of apoptosis (BAX, BAK and BOK) that are essential for the execution of apoptosis, and the BH3-only proteins (BID, PUMA, NOXA, BIM, BIK, HRK, BAD and BMF) that initiate apoptosis (Czabotar et al , 2014).”
InfluentialSelf-citationHeo, Y., Shin, S., Kim, D., Lee, S., Park, S., Baek, S., Lee, J., Kim, J. H., & Han, D. K. (2022) · Biomaterials Science · doi:10.1039/d1bm01846a · Cited by 40
Kwag, D., Cho, B., Bang, S.-Y., Lee, J. H., Min, G. J., Park, S., Park, S., Yoon, J., Lee, S., Eom, K., et al. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00770-x · Cited by 44
“B-cell lymphoma-2 (BCL-2) is an anti-apoptotic protein that allows cancer cells to evade apoptosis by sequestering proapoptotic proteins [4].”
BackgroundNiacin alleviates TRAIL-mediated colon cancer cell death via autophagy flux activation
Kim, S.-W., Lee, J., Moon, J.-H., Nazim, U. M., Lee, Y.-J., Seol, J., Hur, J., Eo, S. K., Lee, J. H., & Park, S. (2015) · Oncotarget · doi:10.18632/oncotarget.5374 · Cited by 42
“Apoptosis-related factors such as fas and caspases enhance apoptosis, whereas several members of the Bcl-2 family inhibit apoptosis [11, 12].”
BackgroundFan, Z., Yu, H., Cui, N., Kong, X., Liu, X., Chang, Y., Wu, Y., Sun, L., & Wang, G. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.016 · Cited by 42
JNK1 Inhibition Attenuates Hypoxia-Induced Autophagy and Sensitizes to Chemotherapy
Vasilevskaya, I. A., Selvakumaran, M., Roberts, D., & O'Dwyer, P. J. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0035 · Cited by 43
“Bcl2-family proteins are indispensable for an intrinsic apoptosis induced by multiple stimuli (41), DNA damage in particular.”
Background
Metadata
- Authors
- Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Strasser, Andreas
- Adams, Jerry M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2013-12-20
- Volume
- 15
- Issue
- 1
- Pages
- 49-63
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2088883749
- Cited by
- 3,219
- References
- 218
- Citations by year
- 2026: 164 · 2025: 220 · 2024: 249 · 2023: 230 · 2022: 265 · 2021: 319 · 2020: 299 · 2019: 285 · 2018: 314 · 2017: 292 · 2016: 287 · 2015: 209 · 2014: 77 · 2013: 1
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2 family proteins, apoptosis, mitochondrial outer membrane, BCL-2 inhibitor, cancer therapy, autoimmune disease, neurodegeneration, ischemia, apoptosis regulation
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Sequence Data, Neoplasms, Signal Transduction, Apoptosis, Protein Structure, Secondary, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Protein Multimerization, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.